T1	Participants 185 237	Keihanshin Study Group of Hematological Malignancies
T2	Participants 435 479	patients with tumors of hematopoietic organs
T3	Participants 856 872	patients (55/93)
#1	AnnotatorNotes T3	total number of patients-93 -includes both male and female
